Intrinsic Value of S&P & Nasdaq Contact Us

Propanc Biopharma, Inc. PPCB NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • AU • USD

SharesGrow Score
28/100
0/4 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Statistics — PPCB

Propanc Biopharma, Inc. (PPCB) has a market capitalization of $1.48M and trades at $0.10. The 52-week range is 0.1022-11.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0, Earnings Per Share (EPS) of $-14.85.

The stock has a beta of 3.53, operates in the Healthcare sector.

Trading Data
Current Price$0.10
52-Week Range0.1022-11
Volume403.87K
Avg Volume (30D)2.25M
Market Cap$1.48M
Beta (1Y)3.53
Company
IPO Date2012-11-12
Employees1
CEOJames Nathanielsz
CountryAU
ExchangeNASDAQ Capital Marke
CurrencyUSD
ISINUS74346N7012
CUSIP74346N404
Income (Latest Year)
EBITDA$-58.34M
Operating Income$-57.28M
Net Income$-58.92M
EPS$-14.85
EPS Diluted$-14.85
Shares Outstanding$3.97M
Balance Sheet (Latest Year)
Total Assets$19.63M
Current Assets$8.35M
Cash & ST Investments$12.09K
Total Liabilities$5.73M
Total Debt$1.73M
Net Debt$1.71M
Total Equity$13.91M
Debt / Equity0.12
Valuation Ratios
P/E Ratio-0
P/B Ratio0.11
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message